SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* HERSHBERG ROBERT (Last) (First) (Middle) C/O FATE THERAPEUTICS, INC. 3535 GENERAL ATOMICS COURT, SUITE 200 (Street) SAN DIEGO CA 92121 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 05/01/2020	3. Issuer Name and Ticker or Trading Symbol FATE THERAPEUTICS INC [ FATE ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner Officer (give title below) Other (specify below)	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

No securities are beneficially owned.

	/s/ Cindy R. Tahl, as Attorney-in-Fact	05/05/2020
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

LIMITED POWER OF ATTORNEY

The undersigned hereby constitutes and appoints Cindy R. Tahl and J. Scott
Wolchko with full power of substitution, the undersigned's true and lawful
attorney-in-fact to:

	(1)	execute for and on behalf of the undersigned, in the undersigned's
		capacity as an officer and/or director of Fate Therapeutics, Inc.
		(the "Company"), from time to time the following U.S. Securities
		and Exchange Commission ("SEC") forms:(i) Form ID, including any attached
		documents, to effect the assignment of codes to the undersigned to be used
		in the transmission of information to the SEC using the EDGAR System;
		(ii) Form 3, Initial Statement of Beneficial Ownership of Securities,
		including any attached documents; (iii) Form 4, Statement of Changes
		in Beneficial Ownership of Securities, including any attached documents;
		(iv) Form 5, Annual Statement of Beneficial Ownership of Securities in
		accordance with Section 16(a) of the Securities Exchange Act of 1934, as
		amended, and the rules thereunder, including any attached documents;
		(v) Schedule 13D and (vi) amendments of each thereof, in accordance with
		the Securities Exchange Act of 1934, as amended, and the rules thereunder,
		including any attached documents;
	(2)	do and perform any and all acts for and on behalf of the undersigned
		which may be necessary or desirable to complete and execute any such
		Form 3, 4 or 5, Schedule 13D or any amendment(s) thereto, and timely file
		such form(s) with the SEC and any securities exchange, national association
		or similar authority; and
	(3)	take any other action of any type whatsoever in connection with the
		foregoing which, in the opinion of such attorney-in-fact, may be of benefit
		to, in the best interest of, or legally required by, the undersigned, it
		being understood that the documents executed by such attorney-in-fact on
		behalf of the undersigned pursuant to this Power of Attorney shall be in
		such form and shall contain such terms and conditions as such
		attorney-in-fact may approve in such attorney-in-fact's discretion.

The undersigned hereby grants to each such attorney-in-fact, acting singly,
full power and authority to do and perform any and every act and thing
whatsoever requisite, necessary or proper to be done in the exercise of any
of the rights and powers herein granted, as fully to all intents and
purposes as the undersigned might or could do if personally present, with full
power of substitution or revocation, hereby ratifying and confirming all that
such attorney-in-fact, or such attorney-in-fact's substitute or substitutes,
shall lawfully do or cause to be done by virtue of this power of attorney
and the rights and powers herein granted.  The undersigned acknowledges that
the foregoing attorneys-in-fact, in serving in such capacity at the request
of the undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 or Regulation 13D-G
of the Securities Exchange Act of 1934, as amended.  The undersigned
hereby agrees to indemnify the attorney in fact and the Company from and
against any demand, damage, loss, cost or expense arising from any false
or misleading information provided by the undersigned to the attorney-in fact.

This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file such forms with respect to the
undersigned's holdings of and transactions in securities issued by the
Company, unless earlier revoked by the undersigned in a signed writing
delivered to the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney
to be executed as of May 4, 2020.
/s/ Robert Hershberg
Robert Hershberg